[Skip to Navigation]
August 1978

A Pyridoxine-Dependent Behavioral Disorder Unmasked by Isoniazid

Author Affiliations

From the Department of Pediatrics, University of Maryland School of Medicine, Baltimore. Dr Brenner is in private practice; Dr Wapnir is now with the North Shore University Hospital, Manhasset, NY.

Am J Dis Child. 1978;132(8):773-776. doi:10.1001/archpedi.1978.02120330045011

• A 3-year-old girl had behavioral deterioration, with hyperkinesis, irritability, and sleeping difficulties after the therapeutic administration of isoniazid. The administration of pharmacologic doses of pyridoxine hydrochloride led to a disappearance of symptoms. After discontinuing isoniazid therapy a similar pattern of behavior was noted that was controlled by pyridoxine. A placebo had no effect, but niacinamide was as effective as pyridoxine. Periodic withdrawal of pyridoxine was associated with return of the hyperkinesis. The level of pyridoxal in the blood was normal during the periods of relapse. Metabolic studies suggested a block in the kynurenine pathway of tryptophan metabolism. The patient has been followed for six years and has required pharmacologic doses of pyridoxine to control her behavior.

(Am J Dis Child 132:773-776, 1978)

Add or change institution